Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, et al. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol. 2019;25:4850–69. https://doi.org/10.3748/wjg.v25.i33.4850.

Article  PubMed  PubMed Central  Google Scholar 

Hoendervangers S, Burbach JPM, Lacle MM, Koopman M, van Grevenstein WMU, Intven MPW, et al. Pathological complete response following different neoadjuvant treatment strategies for locally advanced rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2020;27:4319–36. https://doi.org/10.1245/s10434-020-08615-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin JK, Huh JW, Lee WY, Yun SH, Kim HC, Cho YB, et al. Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer. Sci Rep. 2022;12:7145. https://doi.org/10.1038/s41598-022-10974-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conroy T, Bosset J-F, Etienne P-L, Rio E, François É, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702–15. https://doi.org/10.1016/S1470-2045(21)00079-6.

Article  CAS  PubMed  Google Scholar 

Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM-K, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:29–42. https://doi.org/10.1016/S1470-2045(20)30555-6.

Article  CAS  PubMed  Google Scholar 

López-Campos F, Martín-Martín M, Fornell-Pérez R, García-Pérez JC, Die-Trill J, Fuentes-Mateos R, et al. Watch and wait approach in rectal cancer: current controversies and future directions. World J Gastroenterol. 2020;26:4218–39. https://doi.org/10.3748/wjg.v26.i29.4218.

Article  PubMed  PubMed Central  Google Scholar 

Smith JJ, Paty PB, Garcia-Aguilar J. Watch and wait in rectal cancer or more wait and see? JAMA Surg. 2020;155:657–8. https://doi.org/10.1001/jamasurg.2020.0226.

Article  PubMed  PubMed Central  Google Scholar 

Wang Q, Zhang R, Xiao W, Zhang S, Wei M, Li Y, et al. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy. Radiat Oncol. 2021;16:16. https://doi.org/10.1186/s13014-021-01746-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khalid A, Aloul Z, Chouhan H, Khalid A, Aloul Z, Chouhan H. Radical vs. local excision in rectal carcinoma T1N0M0: recurrence and mortality rates. Cureus. 2022. https://doi.org/10.7759/cureus.25433.

Article  PubMed  PubMed Central  Google Scholar 

Smits LJH, van Lieshout AS, Grüter AAJ, Horsthuis K, Tuynman JB. Multidisciplinary management of early rectal cancer – the role of surgical local excision in current and future clinical practice. Surg Oncol. 2022;40:101687. https://doi.org/10.1016/j.suronc.2021.101687.

Article  PubMed  Google Scholar 

Attia AM, Farrag A, Attia NM, Khalaf LM, Hassan HM, Ameen MG, et al. Signet ring cell component predicts the response to neoadjuvant chemoradiotherapy in rectal cancer. Long interim results of a single institution experience. Am J Cancer Res. 2022;12:1156–68.

PubMed  PubMed Central  Google Scholar 

Bates DDB, Homsi ME, Chang KJ, Lalwani N, Horvat N, Sheedy SP. MRI for rectal cancer: staging, mrCRM, EMVI, lymph node staging and post-treatment response. Clin Colorectal Cancer. 2022;21:10–8. https://doi.org/10.1016/j.clcc.2021.10.007.

Article  PubMed  Google Scholar 

Inoue A, Sheedy SP, Heiken JP, Mohammadinejad P, Graham RP, Lee HE, et al. MRI-detected extramural venous invasion of rectal cancer: multimodality performance and implications at baseline imaging and after neoadjuvant therapy. Insights Imaging. 2021;12:110. https://doi.org/10.1186/s13244-021-01023-4.

Article  PubMed  PubMed Central  Google Scholar 

Shao K, Zheng R, Li A, Li X, Xu B. Clinical predictors of pathological good response in locally advanced rectal cancer. Radiat Oncol. 2021;16:10. https://doi.org/10.1186/s13014-020-01741-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan Y, Fu D, Li D, Kong X, Jiang K, Chen L, et al. Predictors and risk factors of pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer: a population-based analysis. Front Oncol. 2019;9:497. https://doi.org/10.3389/fonc.2019.00497.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Q, Liang J, Chen J, Mei S, Wang Z. Predictive factors for pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Asian Pac J Cancer Prev. 2021;22:1607–11. https://doi.org/10.31557/APJCP.2021.22.5.1607.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng L, Liu Z, Li C, Li Z, Lou X, Shao L, et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health. 2022;4:e8–17. https://doi.org/10.1016/S2589-7500(21)00215-6.

Article  CAS  PubMed  Google Scholar 

Shahzadi I, Zwanenburg A, Lattermann A, Linge A, Baldus C, Peeken JC, et al. Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models. Sci Rep. 2022;12:10192. https://doi.org/10.1038/s41598-022-13967-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749–62. https://doi.org/10.1038/nrclinonc.2017.141.

Article  PubMed  Google Scholar 

Shin J, Seo N, Baek S-E, Son N-H, Lim JS, Kim NK, et al. MRI radiomics model predicts pathologic complete response of rectal cancer following chemoradiotherapy. Radiology. 2022;303:351–8. https://doi.org/10.1148/radiol.211986.

Article  PubMed  Google Scholar 

Bordron A, Rio E, Badic B, Miranda O, Pradier O, Hatt M, et al. External validation of a radiomics model for the prediction of complete response to neoadjuvant chemoradiotherapy in rectal cancer. Cancers. 2022;14:1079. https://doi.org/10.3390/cancers14041079.

Article  PubMed  PubMed Central  Google Scholar 

van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B. Radiomics in medical imaging—“how-to” guide and critical reflection. Insights Imaging. 2020;11:91. https://doi.org/10.1186/s13244-020-00887-2.

Article  PubMed  PubMed Central  Google Scholar 

Litvin AA, Burkin DA, Kropinov AA, Paramzin FN. Radiomics and digital image texture analysis in oncology (review). Mod Technol Med. 2021;13:97–104. https://doi.org/10.17691/stm2021.13.2.11.

Article  CAS  Google Scholar 

Alexandrescu ST, Dumitru AV, Babiuc RD, Costea RV. Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications. Rom J Morphol Embryol. 2021;62:411–25. https://doi.org/10.47162/RJME.62.2.07.

Article  PubMed  Google Scholar 

Gani C, Gani N, Zschaeck S, Eberle F, Schaeffeler N, Hehr T, et al. Organ preservation in rectal cancer: the patients’ perspective. Front Oncol. 2019;9:318.

Article  PubMed  PubMed Central  Google Scholar 

Van Wickle JD, Paulson ES, Landry JC, Erickson BA, Hall WA. Adaptive radiation dose escalation in rectal adenocarcinoma: a review. J Gastrointest Oncol. 2017;8:902–14. https://doi.org/10.21037/jgo.2017.07.06.

Article  PubMed  PubMed Central  Google Scholar 

Bourbonne V, Schick U, Pradier O, Visvikis D, Metges J-P, Badic B. Radiomics approaches for the prediction of pathological complete response after neoadjuvant treatment in locally advanced rectal cancer: ready for prime time? Cancers. 2023;15:432. https://doi.org/10.3390/cancers15020432.